I'm sure they didn't reinvest with Dr. Sacha to come up empty...the subject matter has always been the use of LERONLIMAB...butt,... on that note...I believe it's a five-year march...and like ALL trials ...exploratory in nature....as to specifics...I'll leave that to those that know.